Vanguard Group’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.9M | Buy |
|
|||||
|
2025
Q1 | $21.5M | Sell |
|
|||||
|
2024
Q4 | $31.4M | Buy |
|
|||||
|
2024
Q3 | $24M | Buy |
|
|||||
|
2024
Q2 | $7.39M | Buy |
|
|||||
|
2024
Q1 | $9.27M | Buy |
|
|||||
|
2023
Q4 | $5.7M | Buy |
|
|||||
|
2023
Q3 | $3.94M | Buy |
|
|||||
|
2023
Q2 | $5.48M | Sell |
|
|||||
|
2023
Q1 | $4.86M | Sell |
|
|||||
|
2022
Q4 | $4.53M | Buy |
|
|||||
|
2022
Q3 | $7.03M | Buy |
|
|||||
|
2022
Q2 | $3.96M | Buy |
|
|||||
|
2022
Q1 | $3.5M | Buy |
|
|||||
|
2021
Q4 | $2.83M | Sell |
|
|||||
|
2021
Q3 | $3.89M | Buy |
|
|||||
|
2021
Q2 | $4.74M | Buy |
|
|||||
|
2021
Q1 | $4.27M | Buy |
|
|||||
|
2020
Q4 | $1.05M | Buy |
|
|||||
|
2020
Q3 | $631K | Buy |
|
|||||
|
2020
Q2 | $241K | Buy |
|
|||||
|
2020
Q1 | $35K | Hold |
|
|||||
|
2019
Q4 | $38K | Sell |
|
|||||
|
2019
Q3 | $111K | Sell |
|
|||||
|
2019
Q2 | $100K | Sell |
|
|||||
|
2019
Q1 | $142K | Hold |
|
|||||
|
2018
Q4 | $125K | Sell |
|
|||||
|
2018
Q3 | $824K | Sell |
|
|||||
|
2018
Q2 | $1.06M | Buy |
|
|||||
|
2018
Q1 | $969K | Sell |
|
|||||
|
2017
Q4 | $1.13M | Buy |
|
|||||
|
2017
Q3 | $1.34M | Buy |
|
|||||
|
2017
Q2 | $70K | Buy |
|
|||||
|
2017
Q1 | $221K | Buy |
|
|||||
|
2016
Q4 | $135K | Buy |
|
|||||
|
2016
Q3 | $96K | Buy |
|
|||||
|
2016
Q2 | $111K | Buy |
|
|||||
|
2016
Q1 | $56K | Hold |
|
|||||
|
2015
Q4 | $69K | Buy |
|
|||||
|
2015
Q3 | $61K | Buy |
|
|||||
|
2015
Q2 | $62K | Buy |
|